b i final report volume 1 of 3 text and summary tables l 7 study title a i3 week dermal toxicity pcmx in mice number wil 304003 director teresa d morris bs initiation date october 19 200l completion july 2 2002 performing laboratory research laboratories inc 1407 george road ashland oh 44805928 sponsor clariant corporation 625 east catawba avenue mount holly nc 28 120 722 compliancestatement this designated was conducted compliance with the united states food drug administration fda good practice standards cfr part 58 standard operating procedures protocol as approved by certificate analysis provided presented appendix it is unknown whether characterization analyses were according to practices glp designed be general accordance japanese ministry health labour welfare mhlw international conference on harmonization
